Oncology Institute insider buys 15,000 TOI shares

Oncology Institute, Inc. major shareholder Jorey Chernett, a more than ten percent owner, reported an open-market purchase of 15,000 shares of common stock on July 10, 2026, at a weighted average price of $5.85 per share.

Rhea-AI Filing Summary

Oncology Institute, Inc. major shareholder Jorey Chernett, a more than ten percent owner, reported an open-market purchase of 15,000 shares of common stock on July 10, 2026, at a weighted average price of $5.85 per share. The purchase was executed in multiple transactions at prices ranging from $5.82 to $5.90 per share, based on the footnote disclosure. Following this transaction, Chernett directly holds 10,630,858 shares of Oncology Institute common stock.

Filing Explained

The filing records a director's 15,000-share open-market purchase, changing his disclosed holdings without reporting an issuer share issuance.

This Form 4 reports that director Jorey Chernett bought 15,000 shares of Oncology Institute common stock on 2026-07-10.

The transaction code P identifies it as an open-market purchase, and the filing gives a weighted-average price of $5.85 per share. His reported direct holdings after the purchase were 10,630,858 shares. The structural effect is therefore at the insider level: the filing reports an increase in the reporting person's disclosed common-stock position through an open-market transaction, rather than an issuer share issuance. The explanation states that the shares were purchased in multiple transactions at prices ranging from $5.82 to $5.90, with the reported $5.85 figure rounded to the nearest cent.

Insider Trade Summary

Net Buyer: 15,000 shares

Net Buy 1 txn

Insider Chernett Jorey

Role 10% Owner

Bought 15,000 shs ($88K)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1	15,000	$5.85	$88K

Holdings After Transaction: Common Stock — 10,630,858 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $5.82 to $5.90, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

Key Figures

Shares purchased: 15,000 shares Weighted average purchase price: $5.85 per share Purchase price range: $5.82–$5.90 per share +1 more

4 metrics

Shares purchased 15,000 shares Open-market purchase of common stock on July 10, 2026

Weighted average purchase price $5.85 per share Average price paid for the 15,000 TOI shares acquired

Purchase price range $5.82–$5.90 per share Range of prices for multiple trades comprising the 15,000-share buy

Shares owned after transaction 10,630,858 shares Direct TOI common stock holdings of Jorey Chernett post-transaction

Key Terms

open-market purchase, weighted average price, ten percent owner

3 terms

open-market purchase financial

"reported an open-market purchase of 15,000 shares of common stock"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

weighted average price financial

"The price reported in Column 4 is a weighted average price, rounded"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

ten percent owner financial

"Jorey Chernett, a more than ten percent owner, reported an open-market"

FAQ

What insider transaction did Oncology Institute (TOI) report for Jorey Chernett?

Oncology Institute reported that major shareholder Jorey Chernett made an open-market purchase of 15,000 shares of common stock on July 10, 2026 at a weighted average price of $5.85 per share.

At what price did Jorey Chernett buy TOI common stock in this Form 4?

Jorey Chernett bought TOI common stock at a weighted average price of $5.85 per share, with individual trades executed in a price range from $5.82 to $5.90 per share, according to the Form 4 footnote.

How many Oncology Institute (TOI) shares does Jorey Chernett own after this transaction?

After the reported purchase, Jorey Chernett directly owns 10,630,858 shares of Oncology Institute common stock. This post-transaction holding reflects ownership following the 15,000-share open-market acquisition disclosed in the Form 4.

Was the TOI insider transaction by Jorey Chernett a purchase or sale?

The reported TOI insider transaction by Jorey Chernett was an open-market purchase of common stock. The Form 4 uses transaction code “P”, indicating a purchase in an open market or private transaction, not a sale or disposition.

Were Jorey Chernett’s TOI share purchases executed in multiple trades?

Yes. The footnote explains that the reported $5.85 price is a weighted average, and the 15,000 shares were purchased in multiple transactions at prices ranging from $5.82 to $5.90 per share, rounded to the nearest cent.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/13/2026 - 11:34 AM Accepted by SEC EDGAR 07/13/2026 - 11:34 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chernett Jorey

(Last) (First) (Middle)

6222 INDIANWOOD TR.

(Street)

BLOOMFIELD HILLS MICHIGAN 48301

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Oncology Institute, Inc. [ TOI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/10/2026		P		15,000	A	$5.85(1)	10,630,858	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $5.82 to $5.90, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

	/s/ Jorey Chernett	07/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)